HDFC Securities flags 17 stocks with up to 83% upside potential post-Q2

HDFC Securities has highlighted 17 stocks offering substantial upside potential in the range of up to 83 percent, based on its analysis of September-quarter results released by listed companies. The brokerage's assessment covers a diverse portfolio of businesses across key sectors of the Indian economy.

The stocks under review span pharmaceuticals, capital markets infrastructure, financial services, healthcare, retail and chemicals. Notable names in the list include Nykaa, a leading beauty and wellness e-commerce platform, and Lupin, one of India's major pharmaceutical manufacturers. The selection also encompasses BSE, the country's leading stock exchange operator, and Zydus Lifesciences, a significant player in the pharmaceutical and healthcare sectors.

The ratings reflect HDFC Securities' conviction in the earnings growth trajectory and valuations of these companies following their latest quarterly performance. The brokerage has maintained its existing ratings on these stocks while incorporating fresh data from second-quarter results into its price targets.

Investors tracking the Indian equity markets will be closely monitoring these stocks for execution on their respective growth plans in coming quarters. The identification of these opportunities comes as Indian corporates navigate a complex macroeconomic environment marked by evolving consumer demand and regulatory developments.